Paper23716995
Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.
Lv WS and 9 others. World J Gastroenterol, 2013. Cited by 73 papers, by iCite.
Cite this record
ConductScience Library. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes. Papers, record 23716995. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23716995
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetic Angiopathies | Major topic |
| Fatty Liver | Major topic |
| Microcirculation | Major topic |
| Aged | |
| Chi-Square Distribution | |
| China | |
| Cross-Sectional Studies | |
| Diabetic Nephropathies | |
| Diabetic Retinopathy | |
| Dyslipidemias | |
| Female | |
| Humans | |
| Hypertension | |
| Logistic Models | |
| Male | |
| Middle Aged | |
| Non-alcoholic Fatty Liver Disease | |
| Obesity | |
| Odds Ratio | |
| Predictive Value of Tests | |
| Prevalence | |
| Risk Factors | |
| Ultrasonography |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14762783 | Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. | Gastroenterology | 2004 | https://conductscience.org/library/papers/14762783 | PubMed |
| 2 | 21478462 | Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. | Diabetes Care | 2011 | https://conductscience.org/library/papers/21478462 | PubMed |
| 3 | 19038040 | Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign? | J Transl Med | 2008 | https://conductscience.org/library/papers/19038040 | PubMed |
| 4 | 19051703 | Clinicopathological profile of hepatic involvement in type-2 diabetes mellitus and its significance. | J Assoc Physicians India | 2008 | https://conductscience.org/library/papers/19051703 | PubMed |
| 5 | 20818974 | Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5. | Diabetes Technol Ther | 2010 | https://conductscience.org/library/papers/20818974 | PubMed |
| 6 | 20335585 | Prevalence of diabetes among men and women in China. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20335585 | PubMed |
| 7 | 19414942 | Concomitant macro and microvascular complications in diabetic nephropathy. | Saudi J Kidney Dis Transpl | 2009 | https://conductscience.org/library/papers/19414942 | PubMed |
| 8 | 20664019 | Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. | Diabetes Care | 2010 | https://conductscience.org/library/papers/20664019 | PubMed |
| 9 | 17729403 | Pathogenesis and management issues for non-alcoholic fatty liver disease. | World J Gastroenterol | 2007 | https://conductscience.org/library/papers/17729403 | PubMed |
| 10 | 21184785 | Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. | J Hepatol | 2011 | https://conductscience.org/library/papers/21184785 | PubMed |
| 11 | 16374859 | Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. | Hepatology | 2006 | https://conductscience.org/library/papers/16374859 | PubMed |
| 12 | 16447287 | Nonalcoholic fatty liver disease: from steatosis to cirrhosis. | Hepatology | 2006 | https://conductscience.org/library/papers/16447287 | PubMed |
| 13 | 19262374 | Nonalcoholic fatty liver disease in type 2 diabetes mellitus. | Curr Opin Endocrinol Diabetes Obes | 2009 | https://conductscience.org/library/papers/19262374 | PubMed |
| 14 | 17941863 | Diabetic neuropathy is closely associated with arterial stiffening and thickness in Type 2 diabetes. | Diabet Med | 2007 | https://conductscience.org/library/papers/17941863 | PubMed |
| 15 | 18001543 | [Study on prevalence and risk factors of fatty liver of patients with type 2 diabetes]. | Zhonghua Yi Xue Za Zhi | 2007 | https://conductscience.org/library/papers/18001543 | PubMed |
| 16 | 16953843 | Incretin mimetics as a novel therapeutic option for hepatic steatosis. | Liver Int | 2006 | https://conductscience.org/library/papers/16953843 | PubMed |
| 17 | 19501581 | Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. | Clin Biochem | 2009 | https://conductscience.org/library/papers/19501581 | PubMed |
| 18 | 15727689 | [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai]. | Zhonghua Gan Zang Bing Za Zhi | 2005 | https://conductscience.org/library/papers/15727689 | PubMed |
| 19 | 17547834 | NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes. | Curr Diab Rep | 2007 | https://conductscience.org/library/papers/17547834 | PubMed |
| 20 | 17295757 | Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. | J Gastroenterol Hepatol | 2007 | https://conductscience.org/library/papers/17295757 | PubMed |
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41441969 | Risk of Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatohepatitis: A Retrospective Cohort Study. | Diabetes Ther | 2026 | https://conductscience.org/library/papers/41441969 | PubMed |
| 40894805 | Atherogenic Combined Index is Independently Associated with MASLD in Type 2 Diabetes: A Cross-Sectional Study. | Diabetes Metab Syndr Obes | 2025 | https://conductscience.org/library/papers/40894805 | PubMed |
| 39859020 | Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/39859020 | PubMed |
| 39757660 | Exploring the Prevalence and Coexistence of Metabolic Dysfunction-associated Steatotic Liver Disease in Type 2 Diabetes Mellitus Patients Using Ultrasound: A Cross-sectional Study | Curr Med Imaging | 2025 | https://conductscience.org/library/papers/39757660 | PubMed |
| 38899241 | Nonalcoholic Fatty Liver Disease in Shift Workers and Its Effect on Peripheral Nerve Conduction: A Cross-Sectional Study. | Cureus | 2024 | https://conductscience.org/library/papers/38899241 | PubMed |
| 38232082 | Causal associations between liver enzymes and diabetic microvascular complications: A univariable and multivariable Mendelian randomization. | PLoS One | 2024 | https://conductscience.org/library/papers/38232082 | PubMed |
| 38125279 | A decreased level of high-density lipoprotein is a possible risk factor for type 2 diabetes mellitus: A review. | Health Sci Rep | 2023 | https://conductscience.org/library/papers/38125279 | PubMed |
| 37828942 | Metabolic characteristics of non-obese and obese metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus and its association with diabetic peripheral neuropathy and diabetic retinopathy. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/37828942 | PubMed |
| 37511760 | Retinal Vascular Lesions in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | J Pers Med | 2023 | https://conductscience.org/library/papers/37511760 | PubMed |
| 37342261 | Non-alcoholic fatty liver disease and incidence of microvascular complications of diabetes in patients with type 2 diabetes: a prospective cohort study. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37342261 | PubMed |
| 37002268 | Association between nonalcoholic fatty liver disease and peripheral neuropathy in US population, a cross-sectional study. | Sci Rep | 2023 | https://conductscience.org/library/papers/37002268 | PubMed |
| 36938188 | Relationship Between Vitamin D Deficiency and Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study From a Tertiary Care Center in Northern India. | Cureus | 2023 | https://conductscience.org/library/papers/36938188 | PubMed |
| 36909318 | Aspartate aminotransferase/alanine aminotransferase ratio was associated with type 2 diabetic peripheral neuropathy in a Chinese population: A cross-sectional study. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/36909318 | PubMed |
| 36744164 | Influence of non-alcoholic fatty liver disease on non-variceal upper gastrointestinal bleeding: A nationwide analysis. | World J Hepatol | 2023 | https://conductscience.org/library/papers/36744164 | PubMed |
| 36526962 | Elevated fasting glucose level increases the risk of fatty liver disease: a 10-year study of 31,154 individuals. | BMC Gastroenterol | 2022 | https://conductscience.org/library/papers/36526962 | PubMed |
| 36458094 | The presence of diabetic retinopathy closely associated with the progression of non-alcoholic fatty liver disease: A meta-analysis of observational studies. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/36458094 | PubMed |
| 36387855 | Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36387855 | PubMed |
| 35978658 | Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus. | World J Hepatol | 2022 | https://conductscience.org/library/papers/35978658 | PubMed |
| 35885657 | Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation Parameter. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/35885657 | PubMed |
| 35268466 | The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. | J Clin Med | 2022 | https://conductscience.org/library/papers/35268466 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GGT1 | 2678 | PubTator's text mining | https://conductscience.org/library/genes/2678 | NCBI Gene |
| GPT | 2875 | PubTator's text mining | https://conductscience.org/library/genes/2875 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23716995
GET https://conductscience.org/api/papers/v1/23716995/references?page=2